The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(R*,R*)-2-Amino-3-hydroxy-1-(4-[(4-([4-(hydroxymethyl)phenyl]ethynyl)phenyl)methyl]piperidin-1-yl)-4-(methanesulfonyl)butan-1-one ID: ALA4756867
PubChem CID: 155289365
Max Phase: Preclinical
Molecular Formula: C26H32N2O5S
Molecular Weight: 484.62
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)C[C@H](O)[C@@H](N)C(=O)N1CCC(Cc2ccc(C#Cc3ccc(CO)cc3)cc2)CC1
Standard InChI: InChI=1S/C26H32N2O5S/c1-34(32,33)18-24(30)25(27)26(31)28-14-12-22(13-15-28)16-21-8-4-19(5-9-21)2-3-20-6-10-23(17-29)11-7-20/h4-11,22,24-25,29-30H,12-18,27H2,1H3/t24-,25+/m0/s1
Standard InChI Key: RNBZGRMVKCFVJP-LOSJGSFVSA-N
Molfile:
RDKit 2D
34 36 0 0 0 0 0 0 0 0999 V2000
25.1703 -17.7621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3453 -17.7621 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.7578 -18.4766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6308 -15.7045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3446 -15.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0597 -15.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3433 -14.4660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7735 -15.2887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0610 -16.5273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7761 -16.9387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9177 -15.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2060 -15.6995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2031 -16.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9180 -16.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6359 -16.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4876 -16.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7741 -16.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7783 -15.6967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0656 -15.2828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3492 -15.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3500 -16.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0634 -16.9332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6352 -15.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9163 -14.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2014 -14.4544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2055 -13.6289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4915 -13.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7764 -13.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7797 -14.4595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4943 -14.8676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0611 -13.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3475 -13.6333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3471 -16.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6347 -18.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
5 7 2 0
6 8 1 6
6 9 1 0
9 10 1 0
4 11 1 0
4 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 3 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
28 31 1 0
31 32 1 0
9 33 1 1
33 2 1 0
2 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.62Molecular Weight (Monoisotopic): 484.2032AlogP: 1.09#Rotatable Bonds: 7Polar Surface Area: 120.93Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.53CX Basic pKa: 7.07CX LogP: 0.82CX LogD: 0.66Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.51Np Likeness Score: -0.39
References 1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531 ] [10.1021/acs.jmedchem.0c01215 ] 2. de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L.. (2022) Fragment-to-Lead Medicinal Chemistry Publications in 2020., 65 (1.0): [PMID:34928151 ] [10.1021/acs.jmedchem.1c01803 ]